Cencora, Inc. $COR Shares Sold by Invesco Ltd.

Invesco Ltd. reduced its stake in Cencora, Inc. (NYSE:COR) by 2.3% during the 4th quarter, Holdings Channel reports. The fund owned 3,915,647 shares of the company’s stock after selling 90,466 shares during the quarter. Invesco Ltd.’s holdings in Cencora were worth $1,322,510,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Kemnay Advisory Services Inc. purchased a new stake in Cencora during the 4th quarter worth about $25,000. Oakworth Capital Inc. purchased a new position in shares of Cencora in the 4th quarter valued at about $26,000. Elyxium Wealth LLC acquired a new position in shares of Cencora during the fourth quarter worth about $27,000. Archer Investment Corp grew its position in shares of Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after buying an additional 47 shares in the last quarter. Finally, Motiv8 Investments LLC purchased a new stake in shares of Cencora during the fourth quarter worth approximately $29,000. 97.52% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. UBS Group lifted their price target on shares of Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Robert W. Baird dropped their price objective on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating on the stock in a research report on Thursday, May 7th. Leerink Partners restated an “outperform” rating on shares of Cencora in a report on Tuesday, March 17th. Citigroup decreased their price objective on shares of Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Finally, Morgan Stanley set a $342.00 target price on shares of Cencora in a research note on Friday, May 8th. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $374.00.

Cencora Stock Performance

Shares of COR stock opened at $271.99 on Friday. The stock’s 50-day moving average is $285.65 and its two-hundred day moving average is $324.72. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. Cencora, Inc. has a 1 year low of $244.82 and a 1 year high of $377.54. The firm has a market cap of $52.92 billion, a price-to-earnings ratio of 20.86, a PEG ratio of 1.50 and a beta of 0.59.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing the consensus estimate of $4.82 by ($0.07). The firm had revenue of $78.36 billion during the quarter, compared to analysts’ expectations of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same period in the previous year, the firm posted $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Analysts predict that Cencora, Inc. will post 17.79 earnings per share for the current year.

Cencora Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were paid a $0.60 dividend. The ex-dividend date was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a yield of 0.9%. Cencora’s payout ratio is currently 18.40%.

Cencora declared that its Board of Directors has approved a share repurchase plan on Thursday, May 21st that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to purchase up to 3.9% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.